MAPT and Alzheimer disease: Accumulation of hyperphosphorylated tau protein is a major hallmark of AD, FTD, and other tauopathies that has been strongly associated with cognitive decline (Barthélemy et al., 2020; Carroll et al., 2021) and glucose hypometabolism (Arendt et al., 2015).